JelloX Debut Highlights Potential to Disrupt Cancer Pathology
SAN FRANCISCO, Nov. 8, 2022 /PRNewswire/ — JelloX Biotech’s debut at Intel® Innovation in September drew the attention of healthcare experts and pharmaceutical brands alike for the Taiwan-based startup’s potential to shape the future of cancer pathology using 3D imaging technology. JelloX’s products will help doctors diagnose and treat cancer tumors with greater speed and […]
JelloX Debut Highlights Potential to Disrupt Cancer Pathology Read More »



